A systematic review of the prevalence, risk factors and screening tools for autonomic and diabetic peripheral neuropathy in children, adolescents and young adults with type 1 diabetes
- PMID: 35089443
- DOI: 10.1007/s00592-022-01850-x
A systematic review of the prevalence, risk factors and screening tools for autonomic and diabetic peripheral neuropathy in children, adolescents and young adults with type 1 diabetes
Abstract
Aims: We aimed to estimate the prevalence of Diabetic peripheral neuropathy (DPN) and Cardiac autonomic neuropathy (CAN) in youth with type 1 diabetes; identify key risk factors; identify the most useful tests for the diagnostic evaluation of DPN and CAN; identify key treatment options for DPN and CAN.
Methods: A systematic search was performed including studies published in the last 15 years. PICO framework was used in the selection process and evidence was assessed using the GRADE system.
Results: A total of 758 studies were identified and a final number of 49 studies were included in this systematic review. According to moderate-high level quality studies, the prevalence of probable DPN, ranged between 13.5 and 62%; subclinical DPN between 22 and 88%; confirmed DPN between 2.6 and 11%. The Michigan Neuropathy Screening Instrument was the tool with higher sensitivity and specificity for detecting DPN, which needs to be confirmed by nerve conduction velocity. The prevalence of CAN was 4-39%. Specific treatment options for DPN or CAN in patients younger than 25 years are not available. Key risk factors for DPN and CAN are hyperglycemia/HbA1c, age, diabetes duration, the presence of other microvascular complications, waist/height ratio, lipid profile and blood pressure. For CAN, additional risk factors were cigarette smoking, BMI and total daily insulin.
Conclusions: Prevalence of neuropathy in youth with type 1 diabetes varies depending on different screening methods and characteristics of the study populations. However, the assessed studies confirmed a relatively high prevalence of subclinical neuropathy, reiterating the importance of early identification of risk factors to prevent this complication.
Keywords: Cardiac autonomic neuropathy; Diabetic peripheral neuropathy; Risk factors; Screening tools; Youths.
© 2022. Springer-Verlag Italia S.r.l., part of Springer Nature.
References
-
- Graves LE, Donaghue KC (2019) Management of diabetes complications in youth. Ther Adv Endocrinol Metab 10:2042018819863226. https://doi.org/10.1177/2042018819863226 - DOI - PubMed - PMC
-
- Louraki M, Karayianni C, Kanaka-Gantenbein C, Katsalouli M, Karavanaki K (2012) Peripheral neuropathy in children with type 1 diabetes. Diabetes Metab 38(4):281–289. https://doi.org/10.1016/j.diabet.2012.02.006 - DOI - PubMed
-
- Dabelea D, Stafford JM, Mayer-Davis EJ et al., (2017) Association of Type 1 Diabetes vs Type 2 Diabetes Diagnosed During Childhood and Adolescence With Complications During Teenage Years and Young Adulthood. JAMA 317(8):825–835. https://doi.org/10.1001/jama.2017.0686 - DOI
-
- Tesfaye S, Boulton AJM, Dyck PJ et al. (2010) Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care 33(10):2285–2293. https://doi.org/10.2337/dc10-1303 - DOI
-
- Jaiswal M, Divers J, Urbina EM et al. (2018) Cardiovascular autonomic neuropathy in adolescents and young adults with type 1 and type 2 diabetes: The SEARCH for Diabetes in Youth Cohort Study. Pediatr Diabetes 19(4):680–689. https://doi.org/10.1111/pedi.12633 - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical